This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Lentinus edodes
East Asian culinary mushroom; lentinan polysaccharide approved in Japan as cancer immunotherapy adjunct.
East Asian culinary mushroom; lentinan polysaccharide approved in Japan as cancer immunotherapy adjunct. Key active compounds include lentinan, eritadenine, AHCC.
lentinan, along with eritadenine and AHCC, are the primary bioactive compounds in Lentinus edodes. These compounds disrupts microbial cell membranes and inhibits pathogen growth, supports cardiovascular function through lipid metabolism and vasodilation.
Immunostimulant
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Anti-tumor
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Cardiovascular
Antiviral
Immune support
Based on traditional use; clinical evidence limited
Cancer support
Based on traditional use; clinical evidence limited
Hepatitis
Based on traditional use; clinical evidence limited
HIV
Based on traditional use; clinical evidence limited
Found an error or have a correction for Lentinus edodes?
Report an Issue →